Home
>
National Drug Code (NDC)
>
GUINEA PIG HAIR AND EPITHELIA
GUINEA PIG HAIR AND EPITHELIA - 54575-299-30 - (cavia porcellus hair and cavia porcellus skin)
Drug Information of GUINEA PIG HAIR AND EPITHELIA
| Product NDC: | 54575-299 |
| Proprietary Name: | GUINEA PIG HAIR AND EPITHELIA |
| Non Proprietary Name: | cavia porcellus hair and cavia porcellus skin |
| Active Ingredient(s): | .5; .5 g/20mL; g/20mL & nbsp; cavia porcellus hair and cavia porcellus skin |
| Administration Route(s): | PERCUTANEOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of GUINEA PIG HAIR AND EPITHELIA
| Product NDC: | 54575-299 |
| Labeler Name: | Allergy Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA101376 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19671207 |
Package Information of GUINEA PIG HAIR AND EPITHELIA
| Package NDC: | 54575-299-30 |
| Package Description: | 30 mL in 1 VIAL, MULTI-DOSE (54575-299-30) |
NDC Information of GUINEA PIG HAIR AND EPITHELIA
| NDC Code | 54575-299-30 |
| Proprietary Name | GUINEA PIG HAIR AND EPITHELIA |
| Package Description | 30 mL in 1 VIAL, MULTI-DOSE (54575-299-30) |
| Product NDC | 54575-299 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cavia porcellus hair and cavia porcellus skin |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | PERCUTANEOUS; SUBCUTANEOUS |
| Start Marketing Date | 19671207 |
| Marketing Category Name | BLA |
| Labeler Name | Allergy Laboratories, Inc. |
| Substance Name | CAVIA PORCELLUS HAIR; CAVIA PORCELLUS SKIN |
| Strength Number | .5; .5 |
| Strength Unit | g/20mL; g/20mL |
| Pharmaceutical Classes | Non-Standardized Animal Hair Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Fur [Chemical/Ingredient],Non-Standardized Animal Skin Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Cells, Epidermal [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
